Literature DB >> 9895253

Management of hemorrhage after percutaneous renal surgery.

M Gallucci1, P Fortunato, M Schettini, A Vincenzoni.   

Abstract

Percutaneous renal surgery is routine therapy for a number of renal pathologies. It is a technique not without complications, often serious ones, of which the worst is bleeding. We reviewed our experience of the incidence, etiology, and management of this serious complication to determine a protocol of treatment that will minimize the consequences. Between 1984 and 1996, we carried out 976 percutaneous operations for reno-calix stones, pyeloureteral junction stenosis, neoplasia of the renal pelvis, diagnosis, and ureteral prostheses. In all cases, the percutaneous access was achieved through a lower calix in the posterior axillary line with the patient in a prone position. The lithotripsy was performed with ultrasound and balistic energy lithotripters. Antegrade endopyelotomy was performed according to our technique. At the end of the procedure, a nephrostomy tube was positioned, 24F for lithotripsy and 16F for endopyelotomy. The nephrostomy tube was removed after 24 to 48 hours. In this series, 146 patients (15%) presented significant perioperative bleeding. In 97 cases (10%), this complication was resolved with the repositioning of the nephrostomy tube, bedrest in a supine position, and observation, whereas in 49 cases (5%), clamping of the nephrostomy tube for 24 hours was necessary. In 56 patients (5.7%), two blood transfusions were necessary, and three patients (0.3%) had bleeding 10, 12, and 20 days after the operation, which was resolved by embolization of the lacerated vessel.

Entities:  

Mesh:

Year:  1998        PMID: 9895253     DOI: 10.1089/end.1998.12.509

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  9 in total

1.  Failure of initial superselective renal arterial embolization in the treatment of renal hemorrhage after percutaneous nephrolithotomy: A respective analysis of risk factors.

Authors:  Qiqi Mao; Chaojun Wang; Geming Chen; Fuqing Tan; Bohua Shen
Journal:  Exp Ther Med       Date:  2019-09-20       Impact factor: 2.447

2.  Keyhole surgery of the kidney at sultan qaboos university hospital, oman.

Authors:  Mohammed S Al-Marhoon; Josephkunju Mathew; Hawraa Al-Lawati
Journal:  Sultan Qaboos Univ Med J       Date:  2007-08

3.  Complete obliteration of post percutaneous nephrolithotomy (PCNL) pseudoaneurysm following administration of tranexamic acid.

Authors:  Santosh Kumar; Sudheer Kumar Devana; Shrawan Kumar Singh; Ankur Mittal
Journal:  Urolithiasis       Date:  2013-04-21       Impact factor: 3.436

4.  Does percutaneous nephrolithotomy cause elevated cardiac troponins?

Authors:  Hassan Shemirani; Reza Khanjani; Mehrdad Mohammadi-Sichani; Sarah Mozafarpour; Majid Rabbani; Javad Shahabi
Journal:  ARYA Atheroscler       Date:  2014-01

5.  Tubeless percutaneous nephrolithotomy is effective and safe in short- and long-term urinary drainage.

Authors:  Umut Gonulalan; Tufan Cicek; Okan Istanbulluoglu; Murat Kosan; Bulent Ozturk; Hakan Ozkardes
Journal:  Urolithiasis       Date:  2013-04-21       Impact factor: 3.436

6.  Vascular injuries after percutaneous renal procedures: treatment by transcatheter embolization.

Authors:  Claudio Vignali; Simone Lonzi; Irene Bargellini; Roberto Cioni; Pasquale Petruzzi; Davide Caramella; Carlo Bartolozzi
Journal:  Eur Radiol       Date:  2003-11-19       Impact factor: 5.315

7.  Delayed migration of embolized coil with large renal stone formation: a rare presentation.

Authors:  Santosh Kumar; Kumar Jayant; Shrawan K Singh; Kalpesh M Parmar; Sudheer K Devana; Gautam R Choudhari; Ankur Mittal
Journal:  Case Rep Urol       Date:  2014-12-24

Review 8.  Current insights on haemorrhagic complications in percutaneous nephrolithotomy.

Authors:  Sujeet Poudyal
Journal:  Asian J Urol       Date:  2021-05-29

9.  Decreased hemoglobin as a quantifiable indicator of renal arterial embolization in post-percutaneous nephrolithotomy hemorrhage.

Authors:  Ruitu Ran; Ruiyuan Zhang; Ye Xie; Zhikang Yin
Journal:  Urolithiasis       Date:  2020-08-08       Impact factor: 3.436

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.